VSN Secretariat and Advisory Group

VSN Secretariat and Advisory Group

VSN Secretariat and Advisory Group

Last update: 10 February 2017

Vaccine Safety Net Secretariat

 

 

Mrs Isabelle Sahinovic is an international expert in project management. Before joining WHO headquarters, Isabelle spent more than fifteen years working in emergency and relief operations, post crisis health systems rehabilitation, mainly in Eastern Europe and Africa. Isabelle is coordinating the Vaccine Safety Net and participating to the Global Vaccine Safety Initiative management as a member of the Safety and Vigilance (SAV) team at WHO.

 

Dr Smaragda Lamprianou holds an MSc in Neuropharmacology, a PhD in Neuronal Physiology (Pasteur, Paris) and a Post Graduate Diploma in Global Health Policy (London School of Hygiene and Tropical Medicine).  Her research experience in vaccination and immunology included involvement on the development of a vaccine against Alzheimer's disease. She was also a scientific adviser to the Greek delegation during the 64th and 67th World Health Assembly.

 

Ms. Alma Sokolovic-Rasmussen is a Communication Consultant with a broad expertise in web-communication, web-development, project management, design and online collaboration / communities. Alma’s background is in Communication for Development (MA) and Design (BA), and she has 20 years of experience on projects with the World Bank, UNICEF, UNDP, UNOPS/UNISDR, and most recently, with WHO on the ‘Immunize Europe Forum’.

 

VSN Advisory Group

 

Dr Robert Pless is currently medical advisor to the Vaccine Safety Section of the Surveillance and Epidemiology Division of the Centre for Immunization and Respiratory Infectious Diseases at the Public Health Agency of Canada, with a special interest in communication issues. Since 2015, he is the WHO Global Advisory Committee on Vaccine Safety chairperson.

 

Mrs Catharina de Kat is a Communications, Web and Information Officer, Vaccine-preventable Diseases and Immunization programme (VPI) of the WHO/Europe. Prior to her current position, she worked as a consultant in the web communications team of WHO/Europe, and as an editor, web editor and translator for academic publishers and nongovernmental organizations.

 

Dr Alberto Tozzi  is a pediatrician and an epidemiologist at the Bambino Gesù Children's Hospital where he is responsible of a research area and of a telemedicine unit. He has participated in several studies on vaccines at national and international level. He has been a component of the Expert Vaccine Group of the European Center for Diseases Control. He has published papers on use of web traces for epidemiological surveillance purposes. He is currently running a study to monitor public information needs on vaccines, based on internet monitoring.

 

Dr Suleman Malik

Suleman Malik is currently working as C4D Specialist in the Immunization Unit, UNICEF HQs with focus on the Polio Endgame, and strengthening routine immunization programmes. Suleman led C4D teams in Malawi and Kenya before joining the HQs from his most recent post as Chief of C4D in Myanmar. Over his last 16 years with UNICEF, Suleman supported the development of sev­eral innovative communication initiatives that live on to this day, including gender equity programming in Pakistan, a holistic communication strategy for Child Survival and Development in East Africa, and a children-led edu-tainment initiative in Kenya to promote hand-washing, which has since been replicated in many countries.

 

Dr Jane Gidudu
Dr Gidudu is a physician with several years of field epidemiology and vaccine safety experience globally. Most of her work focused on developing standardized tools & guidance for scientists to advance the understanding of vaccine safety in both resource-rich and resource-poor settings. She has conducted vaccine safety studies in clinical trial and post-marketing settings. She currently works with the Global Immunization Division, at the US. Centers for Disease Control and Prevention (CDC), Atlanta. She provides oversight for vaccine safety activities collaborating with several partners to support the implementation of WHO’s Global Vaccine Safety Initiative(GVSI) activities.